Interferon induces up-regulation of Spi-1/PU.1 in human leukemia K562 cells

被引:10
|
作者
Gutierrez, P
Delgado, MD
Richard, C
MoreauGachelin, F
Leon, J
机构
[1] UNIV CANTABRIA,DEPT BIOL MOL,SANTANDER 39011,SPAIN
[2] HOSP UNIV MARQUES DE VALDECILLA,SERV HEMATOL,SANTANDER,SPAIN
[3] INST CURIE,INSERM,U248,PARIS,FRANCE
关键词
D O I
10.1006/bbrc.1997.7760
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human K562 cell line is derived from a chronic myelogenous leukemia in blastic crisis. Treatment of K562 cells with interferons alpha, beta or gamma resulted in inhibition of cell proliferation. Spi-1/PU.1 is a transcription factor of the Ets family which is required for normal hematopoyesis. We have found that spi-1 mRNA and protein as well as Spi-1-DNA binding activity increase after exposure of K562 cells to interferons. The increase in spi-1 expression ranged from 4- to 8-fold with the different interferons. K562 cells can be differentiated in vitro towards erythroid cells or monocyte-macrophage cells. Interestingly, the regulation of spi-1 by interferon-alpha depended on the differentiated phenotype of K562 cells: interferon-alpha failed to induce spi-1 in erythroid differentiated cells, whereas it induced spi-1 in monocyte-macrophage differentiated cells. The results suggest a role for Spi-1 in the cytostatic response to interferons. (C) 1997 Academic Press.
引用
收藏
页码:862 / 868
页数:7
相关论文
共 50 条
  • [41] Cytomegalovirus IE2 protein stimulates interleukin 1β gene transcription via tethering to Spi-1/PU.1
    Wara-Aswapati, N
    Yang, ZY
    Waterman, WR
    Koyama, Y
    Tetradis, S
    Choy, BK
    Webb, AC
    Auron, PE
    MOLECULAR AND CELLULAR BIOLOGY, 1999, 19 (10) : 6803 - 6814
  • [42] PU.1/Spi-1 is essential for the B cell-specific activity of the mouse CD72 promoter
    Ying, H
    Chang, JF
    Parnes, JR
    JOURNAL OF IMMUNOLOGY, 1998, 160 (05): : 2287 - 2296
  • [43] Zebrafish SPI-1 (PU.1) marks a site of myeloid development independent of primitive erythropoiesis: Implications for axial patterning
    Lieschke, GJ
    Oates, AC
    Paw, BH
    Thompson, MA
    Hall, NE
    Ward, AC
    Ho, RK
    Zon, LI
    Layton, JE
    DEVELOPMENTAL BIOLOGY, 2002, 246 (02) : 274 - 295
  • [44] Holotoxin A1 Induces Apoptosis by Activating Acid Sphingomyelinase and Neutral Sphingomyelinase in K562 and Human Primary Leukemia Cells
    Yun, Seong-Hoon
    Sim, Eun-Hye
    Han, Sang-Heum
    Han, Jin-Yeong
    Kim, Sung-Hyun
    Silchenko, Alexandra S.
    Stonik, Valentin A.
    Park, Joo-In
    MARINE DRUGS, 2018, 16 (04):
  • [45] DNA-BINDING SPECIFICITIES OF SPI-1/PU.1 AND SPI-B TRANSCRIPTION FACTORS AND IDENTIFICATION OF A SPI-1/SPI-B BINDING-SITE IN THE C-FES/C-FPS PROMOTER
    RAYGALLET, D
    MAO, C
    TAVITIAN, A
    MOREAUGACHELIN, F
    ONCOGENE, 1995, 11 (02) : 303 - 313
  • [46] Spi-1/PU.1 Accelerates Replication Fork Elongation through PP1a Phosphatase-Associated Dephosphorylation of CHK1 in Erythroleukemic Cells
    Rimmele, Pauline
    Guervilly, Jean-Hugues
    Rosselli, Filippo
    Moreau-Gachelin, Francoise
    Guillouf, Christel
    BLOOD, 2014, 124 (21)
  • [47] Dual regulatory role of human cytomegalovirus immediate-early protein in IL1B transcription is dependent upon Spi-1/PU.1
    Yang, ZY
    Wara-aswapati, N
    Yoshida, Y
    Walker, N
    Galson, DL
    Listman, J
    Auron, PE
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 294 (04) : 854 - 863
  • [48] PU.1/interferon regulatory factor interactionsMechanisms of transcriptional regulation
    Sylvia Marecki
    Matthew J. Fenton
    Cell Biochemistry and Biophysics, 2000, 33 : 127 - 148
  • [49] Mitomycin induced apoptosis in human leukemia K562 cells
    Shao, Shu-Li
    Zhao, Bin
    Zhang, Wei-Wei
    Zhao, Wei
    Wu, Guang-hui
    Song, Jin-ping
    ADVANCES IN ENVIRONMENTAL ENGINEERING, 2012, 599 : 71 - 75
  • [50] COMPARISON OF THE EXPRESSION AND FUNCTION OF THE TRANSCRIPTION FACTOR PU.1 (SPI-1 PROTOONCOGENE) BETWEEN MURINE MACROPHAGES AND B-LYMPHOCYTES
    ROSS, IL
    DUNN, TL
    YUE, X
    ROY, S
    BARNETT, CJK
    HUME, DA
    ONCOGENE, 1994, 9 (01) : 121 - 132